Senior insider sale
CEO at EDITAS MEDICINE, INC. — senior position signals high conviction
$57.1K
20.39K shares
What this filing means
O'NEILL GILMORE NEIL plans to sell 20.39K shares of EDITAS MEDICINE, INC. valued at approximately $57.1K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 5/29/2026ACC: 0001650664-26-000052
DirectorOfficer· CEO
Since Jun 2022
20.39K
Shares to sell
$57.1K
Approx. market value
32.96K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Restricted Stock Unit Vesting
Equity Compensation
6/2/2026
32.96KTotal acquired32.96K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
6/2/2026 | Restricted Stock Unit Vesting Equity Compensation | 32.96K | — |
| Total | 32.96K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
5.39K
Market value
$10.9K
3/3/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
15K
Market value
$46.2K
6/3/2026
Total
Units
20.39K
Value
$57.1K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
3/3/2026 | 5.39K | $10.9K | — | Completed |
| Planned — Approximate Date | ||||
6/3/2026 | 15K | $46.2K | NASDAQ | Planned |
| Total | 20.39K | $57.1K | ||